silybin has been researched along with idb 1016 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filburn, CR; Griffin, DW; Kettenacker, R | 1 |
| Berry, DP; Boocock, DJ; Brown, VA; Cai, H; Gescher, AJ; Hoh, CS; Marczylo, TH; Steward, WP | 1 |
| Brown, K; Gescher, AJ; Steward, WP; Verschoyle, RD | 1 |
| Brown, K; Gescher, AJ; Greaves, P; Marsden, DA; Patel, K; Steward, WP; Verschoyle, RD | 1 |
| Flaig, TW; Goyal, A; Greenlee, H; Gustafson, DL; Hansen, RJ; Jacobson, JS; Kelly, K; Ladas, E; Lee, V; Lunghofer, PJ; Narayan, R; Rodriguez, R; Siegel, AB; Tsai, WY; Wu, DP | 1 |
2 trial(s) available for silybin and idb 1016
| Article | Year |
|---|---|
Bioavailability of a silybin-phosphatidylcholine complex in dogs.
Topics: Administration, Oral; Animals; Antioxidants; Area Under Curve; Biological Availability; Dogs; Female; Male; Phosphatidylcholines; Phytotherapy; Plant Extracts; Silybin; Silymarin | 2007 |
A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma.
Topics: Antioxidants; Carcinoma, Hepatocellular; Disease Progression; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Phosphatidylcholines; Silybin; Silybum marianum; Silymarin | 2014 |
3 other study(ies) available for silybin and idb 1016
| Article | Year |
|---|---|
Quantitation of silibinin, a putative cancer chemopreventive agent derived from milk thistle (Silybum marianum), in human plasma by high-performance liquid chromatography and identification of possible metabolites.
Topics: Anticarcinogenic Agents; Chromatography, High Pressure Liquid; Humans; Phosphatidylcholines; Silybin; Silybum marianum; Silymarin; Stereoisomerism | 2007 |
Consumption of silibinin, a flavonolignan from milk thistle, and mammary cancer development in the C3(1) SV40 T,t antigen transgenic multiple mammary adenocarcinoma (TAg) mouse.
Topics: Animals; Antigens, Polyomavirus Transforming; Female; Flavonolignans; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Molecular Structure; Phosphatidylcholines; Silybin; Silybum marianum; Silymarin; Stereoisomerism | 2008 |
Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels.
Topics: Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Chromatography, High Pressure Liquid; Drug Evaluation; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Phosphatidylcholines; Prostatic Neoplasms; Silybin; Silymarin | 2008 |